Salford Lung Study

Anonymized individual participant data from the Salford Lung Study, annotated CRF, protocol, reporting and analysis plan, dataset specification, associated raw dataset, analysis-ready dataset, and clinical study report are available for research proposals SLS Asthma - Primary Effectiveness Analysis (PEA) - This population is defined as all ITT subjects (all randomised subjects who receive at least one prescription of study medication [e.g. FF/VI or Usual Care]) who have an ACT total score of < 20 at baseline (Day 0). This population will be based on the treatment to which the subject was randomised. SLS COPD - Primary Effectiveness Analysis (PEA) - This population comprised all ITT subjects (all randomised subjects who received at least one prescription for study medication [e.g. FF/VI or usual care] who had at least one moderate/severe exacerbation in the year prior to Visit 2 (randomisation), as recorded on the eCRF.

Webpage:
https://www.healthdatagateway.org/dataset/a8f5117e-7523-452f-abf3-ced72f03cb2e

Licence:
Name: HDR UK Innovation Gateway Access
URL: https://www.hdruk.ac.uk/infrastructure/gateway/terms-and-conditions/

Tags:

asthma control copd exacerbations pragmatic trial

More to explore:

1/20

Previous Next   



Need help integrating and/or managing biomedical data?